© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Silk Road Medical, Inc (SILK) stock declined over -0.04%, trading at $27.49 on NASDAQ, down from the previous close of $27.50. The stock opened at $27.49, fluctuating between $27.49 and $27.50 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 26, 2024 | 27.49 | 27.49 | 27.49 | 27.49 | 0 |
| Sep 25, 2024 | 27.49 | 27.49 | 27.49 | 27.49 | 0 |
| Sep 24, 2024 | 27.49 | 27.49 | 27.49 | 27.49 | 0 |
| Sep 23, 2024 | 27.49 | 27.49 | 27.49 | 27.49 | 0 |
| Sep 20, 2024 | 27.49 | 27.49 | 27.49 | 27.49 | 0 |
| Sep 19, 2024 | 27.49 | 27.49 | 27.49 | 27.49 | 0 |
| Sep 18, 2024 | 27.49 | 27.49 | 27.49 | 27.49 | 0 |
| Sep 17, 2024 | 27.49 | 27.49 | 27.49 | 27.49 | 0 |
| Sep 16, 2024 | 27.49 | 27.51 | 27.49 | 27.49 | 2.31M |
| Sep 13, 2024 | 27.48 | 27.50 | 27.48 | 27.50 | 5.77M |
| Sep 12, 2024 | 27.21 | 27.29 | 27.18 | 27.28 | 676.54K |
| Sep 11, 2024 | 27.15 | 27.26 | 27.12 | 27.24 | 803.03K |
| Sep 10, 2024 | 27.10 | 27.19 | 27.07 | 27.19 | 518.8K |
| Sep 09, 2024 | 27.07 | 27.11 | 27.02 | 27.08 | 947.6K |
| Sep 06, 2024 | 27.09 | 27.10 | 27.00 | 27.02 | 1.42M |
| Sep 05, 2024 | 27.10 | 27.12 | 27.01 | 27.02 | 1.46M |
| Sep 04, 2024 | 27.17 | 27.17 | 27.03 | 27.09 | 1.59M |
| Sep 03, 2024 | 27.12 | 27.16 | 27.06 | 27.16 | 1.28M |
| Aug 30, 2024 | 27.10 | 27.13 | 27.08 | 27.11 | 845.34K |
| Aug 29, 2024 | 27.08 | 27.12 | 27.08 | 27.08 | 836.6K |
Silk Road Medical, Inc. operates as an American medical device company, focusing on innovative solutions for carotid artery disease. The firm's product portfolio is specifically engineered to support transcarotid artery revascularization (TCAR) procedures. Among its key offerings is the ENROUTE Transcarotid Neuroprotection System, designed to directly access the common carotid artery and initiate a temporary reversal of blood flow. The company also provides the ENROUTE Transcarotid Stent System, a distinctive stent characterized by its self-expanding and self-tapering capabilities. For streamlined initial entry to the common carotid artery, Silk Road Medical offers the ENHANCE Transcarotid Peripheral Access Kit. Additionally, the ENROUTE 0.014 Guidewire plays a crucial role in navigating and crossing target lesions, enabling the precise delivery of other interventional devices. Founded in 2007, Silk Road Medical, Inc. maintains its primary corporate offices in Sunnyvale, California.
| Employees | 474 |
| Beta | 1.54 |
| Sales or Revenue | $177.13M |
| 5Y Sales Change% | 2.793% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |